METHOD OF TREATING PATIENTS WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY Russian patent published in 2013 - IPC A61N1/30 A61K31/522 A61K38/08 A61P27/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to ophthalmology, endocrinology and restorative medicine, and may be used to treat the patients with non-proliferative diabetic retinopathy. For this purpose, with underlying background individual antidiabetic therapy, endonasal electrophoresis with 0.1% Semax in a daily dose of 700 mcg is applied in a patient lying on his/her back. A bifurcated positive electrode is coated with cotton swabs each of which is moistened with 7 drops of Semax. These electrodes are introduced into the middle nasal passages. At the same time, a cathode spacer of the second negative electrode 8×10 cm is moistened with 2% aminophylline and placed in the back of the neck. The current intensity is 1.2 mA. The exposure length is 20-22 minutes. The therapeutic course is 8-10 sessions, daily or every second day.

EFFECT: provided therapeutic effect in the early stages of the disease, including in the patients with severe comorbidities, as well as slow progression of the retinal pathological process, and stabilised long-term result up to 6 months.

2 ex